TBIO
Telesis Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 27th of September, 2024.
20 hedge funds and large institutions have $4.77M invested in Telesis Bio, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$18.7K | |
| 2 | +$8.8K | |
| 3 | +$1.36K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$178 |
| 5 |
JPMorgan Chase & Co
New York
|
+$16 |
Top Sellers
| 1 | -$141K | |
| 2 | -$28.7K | |
| 3 | -$15K | |
| 4 |
Renaissance Technologies
New York
|
-$11K |
| 5 |
MAM
McCarthy Asset Management
Redwood Shores,
California
|
-$4.39K |